Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adamas Pharmaceuticals Inc (ADMS) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adamas Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1328143.
Total stock buying since 2014: $8,198,776.
Total stock sales since 2014: $27,572,408.
Total stock option exercises since 2014: $771,322.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 5,975 | $30,233 | 22,638 | $126,120 | 240,000 | $159,600 |
| 2020 | 0 | $0 | 3,319 | $14,092 | 0 | $0 |
| 2019 | 0 | $0 | 16,133 | $122,591 | 33,332 | $58,497 |
| 2018 | 3,850 | $49,957 | 13,163 | $315,656 | 0 | $0 |
| 2017 | 0 | $0 | 385,737 | $6,594,102 | 0 | $0 |
| 2016 | 518,236 | $8,118,586 | 36,000 | $666,000 | 240,900 | $427,747 |
| 2015 | 0 | $0 | 905,428 | $17,049,275 | 47,100 | $86,868 |
| 2014 | 0 | $0 | 184,000 | $2,684,572 | 22,000 | $38,610 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-06 | 0 | $0 | 8,200 | $42,325 | 0 | $0 |
| 2021-03 | 5,975 | $30,233 | 3,473 | $19,052 | 240,000 | $159,600 |
| 2021-02 | 0 | $0 | 8,335 | $53,145 | 0 | $0 |
| 2021-01 | 0 | $0 | 2,630 | $11,598 | 0 | $0 |
| 2020-11 | 0 | $0 | 2,050 | $6,580 | 0 | $0 |
| 2020-01 | 0 | $0 | 1,269 | $7,512 | 0 | $0 |
| 2019-09 | 0 | $0 | 1,584 | $10,945 | 33,332 | $58,497 |
| 2019-07 | 0 | $0 | 1,082 | $6,492 | 0 | $0 |
| 2019-06 | 0 | $0 | 940 | $5,029 | 0 | $0 |
| 2019-03 | 0 | $0 | 12,527 | $100,125 | 0 | $0 |
| 2018-12 | 0 | $0 | 653 | $4,908 | 0 | $0 |
| 2018-11 | 3,850 | $49,957 | 0 | $0 | 0 | $0 |
| 2018-09 | 0 | $0 | 1,665 | $31,934 | 0 | $0 |
| 2018-06 | 0 | $0 | 3,503 | $89,255 | 0 | $0 |
| 2018-03 | 0 | $0 | 7,342 | $189,559 | 0 | $0 |
| 2017-12 | 0 | $0 | 440 | $14,211 | 0 | $0 |
| 2017-06 | 0 | $0 | 381,041 | $6,507,412 | 0 | $0 |
| 2017-03 | 0 | $0 | 4,256 | $72,479 | 0 | $0 |
| 2016-09 | 518,236 | $8,118,586 | 0 | $0 | 0 | $0 |
| 2016-06 | 0 | $0 | 0 | $0 | 204,900 | $384,187 |
| 2016-04 | 0 | $0 | 36,000 | $666,000 | 36,000 | $43,560 |
| 2015-12 | 0 | $0 | 3,000 | $48,690 | 0 | $0 |
| 2015-11 | 0 | $0 | 3,000 | $45,000 | 0 | $0 |
| 2015-10 | 0 | $0 | 3,000 | $50,250 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-21 | Shreedhar Vijay (Chief Commercial Officer) | Sale | 6,200 | 5.16 | 31,985 |
| 2021-06-07 | Demski Martha J | Sale | 2,000 | 5.17 | 10,340 |
| 2021-03-22 | Shreedhar Vijay (Chief Commercial Officer) | Sale | 1,051 | 5.50 | 5,780 |
| 2021-03-22 | Prentiss Christopher B (Chief Financial Officer) | Sale | 2,422 | 5.48 | 13,272 |
| 2021-03-12 | Macphee John A (Director) | Option Ex | 192,000 | .67 | 127,680 |
| 2021-03-12 | Mahoney David L (Director) | Option Ex | 48,000 | .67 | 31,920 |
| 2021-03-11 | Papapetropoulos Spyridon (Director) | Buy | 5,975 | 5.06 | 30,233 |
| 2021-02-01 | Shreedhar Vijay (Chief Commercial Officer) | Sale | 4,514 | 6.39 | 28,844 |
| 2021-02-01 | Prentiss Christopher B (Chief Financial Officer) | Sale | 3,821 | 6.36 | 24,301 |
| 2021-01-20 | Prentiss Christopher B (Chief Financial Officer) | Sale | 2,630 | 4.41 | 11,598 |
| 2020-11-02 | Prentiss Christopher B (Chief Financial Officer) | Sale | 2,050 | 3.21 | 6,580 |
| 2020-01-21 | Prentiss Christopher B (Chief Financial Officer) | Sale | 1,269 | 5.92 | 7,512 |
| 2019-09-20 | Merriweather Alfred G (Chief Financial Officer) | Sale | 1,584 | 6.91 | 10,945 |
| 2019-09-17 | Mahoney David L (Director) | Option Ex | 33,332 | 1.75 | 58,497 |
| 2019-07-22 | Prentiss Christopher B (Chief Accounting Officer) | Sale | 1,082 | 6.00 | 6,492 |
| 2019-06-20 | Rhodes Jennifer J (CBO, GC & Compliance Officer) | Sale | 940 | 5.35 | 5,029 |
| 2019-03-20 | Prentiss Christopher B (Chief Accounting Officer) | Sale | 1,185 | 8.00 | 9,480 |
| 2019-03-20 | Patni Rajiv (Chief Medical Officer) | Sale | 2,374 | 8.00 | 18,992 |
| 2019-03-20 | Went Gregory T (Chief Executive Officer) | Sale | 6,319 | 7.99 | 50,488 |
| 2019-03-20 | Rhodes Jennifer J (CBO, GC & Compliance Officer) | Sale | 1,792 | 7.99 | 14,318 |
| 2019-03-20 | Merriweather Alfred G (Chief Financial Officer) | Sale | 857 | 7.99 | 6,847 |
| 2018-12-20 | Prentiss Christopher B (Chief Accounting Officer) | Sale | 228 | 7.51 | 1,712 |
| 2018-12-20 | Rhodes Jennifer J (CBO, GC & Compliance Officer) | Sale | 425 | 7.52 | 3,196 |
| 2018-11-07 | Went Gregory T (Chief Executive Officer) | Buy | 3,850 | 12.98 | 49,957 |
| 2018-09-21 | Merriweather Alfred G (Chief Financial Officer) | Sale | 1,665 | 19.18 | 31,934 |
| 2018-06-21 | Rhodes Jennifer J (CBO, GC & Compliance Officer) | Sale | 1,002 | 25.48 | 25,530 |
| 2018-06-21 | King Richard (Chief Operating Officer) | Sale | 2,501 | 25.48 | 63,725 |
| 2018-03-21 | Prentiss Christopher B (Chief Accounting Officer) | Sale | 567 | 25.98 | 14,730 |
| 2018-03-21 | Patni Rajiv (Chief Medical Officer) | Sale | 1,252 | 25.94 | 32,476 |
| 2018-03-21 | Went Gregory T (Chief Executive Officer) | Sale | 4,541 | 25.75 | 116,930 |
| 2018-03-21 | Rhodes Jennifer J (CBO, GC & Compliance Officer) | Sale | 982 | 25.89 | 25,423 |
| 2017-12-21 | Rhodes Jennifer J (CBO, GC & Compliance Officer) | Sale | 440 | 32.30 | 14,211 |
| 2017-06-21 | Rhodes Jennifer J (CBO, GC & Compliance Officer) | Sale | 1,041 | 17.54 | 18,253 |
| 2017-06-21 | Kroin David | Sale | 10,000 | 17.44 | 174,370 |
| 2017-06-20 | Kroin David | Sale | 20,000 | 17.35 | 346,940 |
| 2017-06-19 | Kroin David | Sale | 350,000 | 17.05 | 5,967,849 |
| 2017-03-21 | Patni Rajiv (Chief Medical Officer) | Sale | 733 | 17.04 | 12,490 |
| 2017-03-21 | Went Gregory T (Chief Executive Officer) | Sale | 2,807 | 17.03 | 47,803 |
| 2017-03-21 | Dawson William J (Chief Financial Officer) | Sale | 716 | 17.02 | 12,186 |
| 2016-09-16 | Ericson William W. (Director) | Buy | 8,240 | 16.81 | 138,497 |
| 2016-09-16 | Mdv Vii Lp (10% Owner) | Buy | 8,240 | 16.81 | 138,497 |
| 2016-09-15 | Ericson William W. (Director) | Buy | 200 | 16.50 | 3,300 |
| 2016-09-15 | Mdv Vii Lp (10% Owner) | Buy | 200 | 16.50 | 3,300 |
| 2016-09-14 | Ericson William W. (Director) | Buy | 54,537 | 16.43 | 895,770 |
| 2016-09-14 | Mdv Vii Lp (10% Owner) | Buy | 54,537 | 16.43 | 895,770 |
| 2016-09-13 | Ericson William W. (Director) | Buy | 62,034 | 15.56 | 965,000 |
| 2016-09-13 | Mdv Vii Lp (10% Owner) | Buy | 62,034 | 15.56 | 965,000 |
| 2016-09-12 | Ericson William W. (Director) | Buy | 22,342 | 15.65 | 349,741 |
| 2016-09-12 | Mdv Vii Lp (10% Owner) | Buy | 22,342 | 15.65 | 349,741 |
| 2016-09-07 | Ericson William W. (Director) | Buy | 60,846 | 15.68 | 954,065 |
| 2016-09-07 | Mdv Vii Lp (10% Owner) | Buy | 60,846 | 15.68 | 954,065 |
| 2016-09-06 | Ericson William W. (Director) | Buy | 7,200 | 15.00 | 107,978 |
| 2016-09-06 | Mdv Vii Lp (10% Owner) | Buy | 7,200 | 15.00 | 107,978 |
| 2016-09-02 | Ericson William W. (Director) | Buy | 43,719 | 14.75 | 644,942 |
| 2016-09-02 | Mdv Vii Lp (10% Owner) | Buy | 43,719 | 14.75 | 644,942 |
| 2016-06-15 | Went Gregory T (Chief Executive Officer) | Option Ex | 204,900 | 1.88 | 384,187 |
| 2016-04-18 | Mcclure Natalie (SVP, Product Development) | Sale | 36,000 | 18.50 | 666,000 |
| 2016-04-18 | Mcclure Natalie (SVP, Product Development) | Option Ex | 36,000 | 1.21 | 43,560 |
| 2015-12-07 | Lieberburg Ivan M (Director) | Sale | 3,000 | 16.23 | 48,690 |
| 2015-11-02 | Lieberburg Ivan M (Director) | Sale | 3,000 | 15.00 | 45,000 |
| 2015-10-05 | Lieberburg Ivan M (Director) | Sale | 3,000 | 16.75 | 50,250 |
| 2015-09-08 | Lieberburg Ivan M (Director) | Sale | 3,000 | 19.13 | 57,390 |
| 2015-08-03 | Lieberburg Ivan M (Director) | Sale | 3,000 | 24.51 | 73,530 |
| 2015-07-10 | Ericson William W. (Director) | Sale | 8,657 | 27.53 | 238,309 |
| 2015-07-10 | Mdv Vii Lp (10% Owner) | Sale | 8,657 | 27.53 | 238,309 |
| 2015-07-08 | Ericson William W. (Director) | Sale | 3,100 | 27.55 | 85,408 |
| 2015-07-08 | Mdv Vii Lp (10% Owner) | Sale | 3,100 | 27.55 | 85,408 |
| 2015-07-07 | Ericson William W. (Director) | Sale | 25,737 | 27.55 | 708,925 |
| 2015-07-07 | Mdv Vii Lp (10% Owner) | Sale | 25,737 | 27.55 | 708,925 |
| 2015-07-06 | Lieberburg Ivan M (Director) | Sale | 3,000 | 25.91 | 77,730 |
| 2015-06-18 | Ericson William W. (Director) | Sale | 15,842 | 27.54 | 436,256 |
| 2015-06-18 | Mdv Vii Lp (10% Owner) | Sale | 15,842 | 27.54 | 436,256 |
| 2015-06-15 | Booth Richard H (Director) | Sale | 1,000 | 19.32 | 19,320 |
| 2015-06-05 | Mcclure Natalie (SVP, Product Development) | Sale | 2,000 | 18.95 | 37,900 |
| 2015-06-05 | Mcclure Natalie (SVP, Product Development) | Option Ex | 2,000 | 1.75 | 3,510 |
| 2015-06-01 | Lieberburg Ivan M (Director) | Sale | 3,000 | 17.93 | 53,790 |
| 2015-05-29 | Ericson William W. (Director) | Sale | 112,073 | 18.02 | 2,019,555 |
| 2015-05-29 | Mdv Vii Lp (10% Owner) | Sale | 112,073 | 18.02 | 2,019,555 |
| 2015-05-28 | Ericson William W. (Director) | Sale | 7,483 | 18.02 | 134,821 |
| 2015-05-28 | Mdv Vii Lp (10% Owner) | Sale | 7,483 | 18.02 | 134,821 |
| 2015-05-18 | Ericson William W. (Director) | Sale | 1,643 | 18.04 | 29,639 |
| 2015-05-18 | Mdv Vii Lp (10% Owner) | Sale | 1,643 | 18.04 | 29,639 |
| 2015-05-15 | Booth Richard H (Director) | Sale | 1,000 | 17.85 | 17,850 |
| 2015-05-14 | Went Gregory T (Chief Executive Officer) | Sale | 300 | 18.00 | 5,400 |
| 2015-05-14 | Went Gregory T (Chief Executive Officer) | Option Ex | 100 | 1.88 | 187 |
| 2015-05-13 | Went Gregory T (Chief Executive Officer) | Sale | 128 | 18.00 | 2,304 |
| 2015-05-13 | Went Gregory T (Chief Executive Officer) | Option Ex | 10,028 | 1.88 | 18,802 |
| 2015-05-12 | Went Gregory T (Chief Executive Officer) | Sale | 2,300 | 18.00 | 41,406 |
| 2015-05-12 | Went Gregory T (Chief Executive Officer) | Option Ex | 500 | 1.88 | 937 |
| 2015-05-05 | Mcclure Natalie (SVP, Product Development) | Sale | 2,000 | 17.62 | 35,240 |
| 2015-05-05 | Mcclure Natalie (SVP, Product Development) | Option Ex | 2,000 | 1.75 | 3,510 |
| 2015-05-04 | Lieberburg Ivan M (Director) | Sale | 3,000 | 16.82 | 50,460 |
| 2015-04-23 | Went Gregory T (Chief Executive Officer) | Sale | 3,300 | 18.00 | 59,406 |
| 2015-04-23 | Went Gregory T (Chief Executive Officer) | Option Ex | 900 | 1.88 | 1,687 |
| 2015-04-21 | Went Gregory T (Chief Executive Officer) | Sale | 2,773 | 18.00 | 49,925 |
| 2015-04-21 | Went Gregory T (Chief Executive Officer) | Option Ex | 962 | 1.88 | 1,803 |
| 2015-04-20 | Went Gregory T (Chief Executive Officer) | Sale | 7,810 | 18.00 | 140,580 |
| 2015-04-20 | Went Gregory T (Chief Executive Officer) | Option Ex | 2,610 | 1.88 | 4,893 |
| 2015-04-15 | Booth Richard H (Director) | Sale | 1,000 | 17.72 | 17,720 |
| 2015-04-14 | Went Gregory T (Chief Executive Officer) | Sale | 10,180 | 12.62 | 128,522 |
| 2015-04-14 | Went Gregory T (Chief Executive Officer) | Option Ex | 80 | 1.88 | 150 |
| 2015-04-10 | Went Gregory T (Chief Executive Officer) | Sale | 4,577 | 18.58 | 85,040 |
| 2015-04-10 | Went Gregory T (Chief Executive Officer) | Option Ex | 1,000 | 1.88 | 1,875 |
| 2015-04-10 | Ericson William W. (Director) | Sale | 37,078 | 18.56 | 688,056 |
| 2015-04-10 | Mdv Vii Lp (10% Owner) | Sale | 37,078 | 18.56 | 688,056 |
| 2015-04-06 | Mcclure Natalie (SVP, Product Development) | Sale | 2,000 | 17.44 | 34,880 |
| 2015-04-06 | Mcclure Natalie (SVP, Product Development) | Option Ex | 2,000 | 1.75 | 3,510 |
| 2015-04-06 | Lieberburg Ivan M (Director) | Sale | 3,000 | 17.44 | 52,320 |
| 2015-03-20 | Went Gregory T (Chief Executive Officer) | Sale | 300 | 18.00 | 5,400 |
| 2015-03-20 | Went Gregory T (Chief Executive Officer) | Option Ex | 100 | 1.88 | 187 |
| 2015-03-19 | Went Gregory T (Chief Executive Officer) | Sale | 4,468 | 18.00 | 80,424 |
| 2015-03-19 | Went Gregory T (Chief Executive Officer) | Option Ex | 12,320 | 1.88 | 23,100 |
| 2015-03-18 | Went Gregory T (Chief Executive Officer) | Sale | 14,020 | 18.00 | 252,402 |
| 2015-03-18 | Went Gregory T (Chief Executive Officer) | Option Ex | 4,600 | 1.88 | 8,625 |
| 2015-03-18 | Ericson William W. (Director) | Sale | 7,200 | 18.04 | 129,895 |
| 2015-03-18 | Mdv Vii Lp (10% Owner) | Sale | 7,200 | 18.04 | 129,895 |
| 2015-03-17 | Went Gregory T (Chief Executive Officer) | Sale | 4,600 | 18.00 | 82,800 |
| 2015-03-17 | Went Gregory T (Chief Executive Officer) | Option Ex | 1,900 | 1.88 | 3,562 |
| 2015-03-17 | Ericson William W. (Director) | Sale | 4,523 | 18.00 | 81,414 |
| 2015-03-17 | Mdv Vii Lp (10% Owner) | Sale | 4,523 | 18.00 | 81,414 |
| 2015-03-16 | Booth Richard H (Director) | Sale | 1,000 | 17.36 | 17,360 |
| 2015-03-13 | Aeris Capital Equity Investments, L.p. (10% Owner) | Sale | 350,000 | 17.23 | 6,030,500 |
| 2015-03-05 | Mcclure Natalie (SVP, Product Development) | Sale | 2,000 | 17.15 | 34,300 |
| 2015-03-05 | Mcclure Natalie (SVP, Product Development) | Option Ex | 2,000 | 1.75 | 3,510 |
| 2015-03-02 | Lieberburg Ivan M (Director) | Sale | 3,000 | 16.97 | 50,910 |
| 2015-02-17 | Booth Richard H (Director) | Sale | 1,000 | 16.54 | 16,540 |
| 2015-02-05 | Mcclure Natalie (SVP, Product Development) | Sale | 2,000 | 16.87 | 33,740 |
| 2015-02-05 | Mcclure Natalie (SVP, Product Development) | Option Ex | 2,000 | 1.75 | 3,510 |
| 2015-02-02 | Lieberburg Ivan M (Director) | Sale | 3,000 | 16.77 | 50,310 |
| 2015-01-15 | Booth Richard H (Director) | Sale | 1,000 | 17.43 | 17,430 |
| 2015-01-05 | Mcclure Natalie (SVP, Product Development) | Sale | 2,000 | 17.59 | 35,180 |
| 2015-01-05 | Mcclure Natalie (SVP, Product Development) | Option Ex | 2,000 | 1.75 | 3,510 |
| 2015-01-05 | Lieberburg Ivan M (Director) | Sale | 3,000 | 17.59 | 52,770 |
| 2014-12-24 | Booth Richard H (Director) | Sale | 2,000 | 17.51 | 35,020 |
| 2014-12-05 | Mcclure Natalie (SVP, Product Development) | Sale | 2,000 | 14.01 | 28,028 |
| 2014-12-05 | Mcclure Natalie (SVP, Product Development) | Option Ex | 2,000 | 1.75 | 3,510 |
| 2014-12-03 | Aeris Capital Equity Investments, L.p. (10% Owner) | Sale | 105,225 | 14.51 | 1,526,288 |
| 2014-12-02 | Aeris Capital Equity Investments, L.p. (10% Owner) | Sale | 6,400 | 14.51 | 92,889 |
| 2014-12-01 | Aeris Capital Equity Investments, L.p. (10% Owner) | Sale | 12,815 | 14.51 | 185,996 |
| 2014-12-01 | Mcclure Natalie (SVP, Product Development) | Sale | 20,000 | 14.50 | 290,000 |
| 2014-12-01 | Mcclure Natalie (SVP, Product Development) | Option Ex | 20,000 | 1.75 | 35,100 |
| 2014-11-28 | Aeris Capital Equity Investments, L.p. (10% Owner) | Sale | 800 | 14.93 | 11,940 |
| 2014-11-26 | Aeris Capital Equity Investments, L.p. (10% Owner) | Sale | 12,500 | 14.77 | 184,662 |
| 2014-11-25 | Aeris Capital Equity Investments, L.p. (10% Owner) | Sale | 5,600 | 14.85 | 83,171 |
| 2014-11-24 | Aeris Capital Equity Investments, L.p. (10% Owner) | Sale | 4,400 | 14.86 | 65,370 |
| 2014-11-21 | Aeris Capital Equity Investments, L.p. (10% Owner) | Sale | 8,760 | 14.81 | 129,779 |
| 2014-11-20 | Aeris Capital Equity Investments, L.p. (10% Owner) | Sale | 3,500 | 14.69 | 51,429 |
Insider trading activities including stock purchases, stock sales, and option exercises of ADMS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adamas Pharmaceuticals Inc (symbol ADMS, CIK number 1328143) see the Securities and Exchange Commission (SEC) website.